Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01745237 · ClinicalTrials.gov registry record
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
A clinical trial of Sarcoidosis, sponsored by Duke University.
- Recruiting
- Registry status
- 27,000
- Enrollment target
- 1
- Study location
NCT01745237: Recruiting study of Sarcoidosis, sponsored by Duke University.
NCT01745237 is a study of Sarcoidosis that is actively recruiting participants, run by Duke University. The registered enrollment target is 27,000 participants, above the 884-participant average among 21 other Sarcoidosis trials with a reported enrollment target (2954% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01745237, a study of Sarcoidosis, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 27,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,000 participants |
| Start Date | 2002-09 |
| Est. Completion | 2032-06 |
What NCT01745237 shows while recruiting
NCT01745237 is an observational study that tracks outcomes without assigning an intervention. Its 27,000 participants enrollment target places it among the larger protocols in the corpus, above the 884-participant average among 21 other Sarcoidosis trials with a reported enrollment target (2954% higher).
The record links to 1 condition, with Sarcoidosis appearing as the primary indexed condition, and to 0 interventions.
NCT01745237 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01745237 about?
NCT01745237 is a clinical study titled "Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis". The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.
What is the current status of trial NCT01745237?
This trial is currently recruiting. The enrollment target is 27,000 participants. The study started on 2002-09. Estimated completion is 2032-06.
What conditions does trial NCT01745237 study?
This clinical trial studies the following conditions: Sarcoidosis.
Who is sponsoring clinical trial NCT01745237?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01745237 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01745237's enrollment target sits among peer trials
27,000 1st of 21 higher than 21 of 21 other Sarcoidosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoidosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
RECRUITING
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
Cardiac Sarcoidosis Randomized Trial
RECRUITING · Phase 3
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
Vitamin D Homeostasis in Sarcoidosis
RECRUITING · Phase 4
-
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia